Lexie is a Cell and Gene Therapy scientist based in Lake Zurich, Illinois, USA. She earned her PhD in cell and molecular biology from West Virginia University and recently completed a postdoctoral fellowship at the University of South Carolina, both with a focus on developing genetic tools. Lexie joined the Fresenius Kabi Research team and now contributes to the EASYGEN Consortium, supporting Work Package 7 by advising on analytical and technical aspects for the development of next-generation CAR-T manufacturing processes and equipment.